Cardea Bio News Today

Paragraf, a Cambridge-based company co-founded by Simon Thomas, is harnessing the potential of graphene, a 2D form of carbon, to revolutionize...

Simon Thomas knew the periodic table by heart at six. Now the Cambridge firm’s co-founder is putting his scientific brain behind graphene’s power to help us compete with China

Celebrating its 10th anniversary, International Women in Engineering Day is an annual event that works to celebrate, promote and support female professionals in the engineering sector worldwide.

/PRNewswire/ -- Today, DARPA, Siemens, US ARMY, Georgia Tech Research Institute, and Paragraf - through recently acquired Cardea Bio, now Paragraf San Diego -...

In March this year, Arm announced that it would be looking to float on the New York Stock Exchange, rather than here in London, and it has now applied to sell its shares in the US in what could prove to be the biggest stock market listing of 2023.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Paragraf, the only company in the world to mass produce graphene electronics using transfer-free graphene and standard semiconductor processes, has acquired Cardea Bio, the world’s leading producer of graphene-based biocompatible chips.

Paragraf, currently the only company in the world to mass produce graphene electronics using transfer-free graphene and standard semiconductor processes, has acquired Cardea Bio, a producer of graphene-based biocompatible chips. Cardea Bio is to be renamed Paragraf USA.

/PRNewswire/ -- The ongoing exhibition Of Genes and Human Beings at the national German DHMD museum in Dresden, highlights multiple technological advances in...

Planar to FinFET to Nanosheet to Complementary FET to 2D